CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Shares withheld for taxes EVP Glob. Prod Strat and Comm gave up 940 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Human Resources gave up 2,182 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Pharmaceutical Oper & Tech gave up 715 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Chief Legal Off & Corp Sec gave up 3,896 shares (to pay taxes)
- 4 Open-market buy Director bought 898 shares at $267.00 ($239,766)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Grant or award EVP Chief Legal Off & Corp Sec acquired 4,545 shares (grant or award)
- 4 Grant or award EVP Pharmaceutical Oper & Tech acquired 818 shares (grant or award)
- 4 Grant or award EVP, Human Resources acquired 2,558 shares (grant or award)
- 4 Grant or award EVP, Research & Development acquired 3,728 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 16,343 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 22 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Glob. Prod Strat and Comm gave up 562 shares (to pay taxes)
- 4 Open-market buy Chief Executive Officer bought 3,100 shares at $241.31 ($748,047)
- 4 Open-market sale EVP, Research & Development sold 1,500 shares at $350.00 ($525,000)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 15 of 86 · 1,714 filings